Protocol No
GI-YARUR-SPARC
Phase
N/A
Summary
Identify predictors of response to IBD therapies from clinical, patient reported, genetic, genomic, transcriptomic, metabolomics, and microbiomic data. Identify predictors of disease relapse among responders to therapies for IBD.
Description
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories